Methods of isolation of active compounds and activated targets

Details for Australian Patent Application No. 2003301960 (hide)

Owner REGENERON PHARMACEUTICALS, INC.

Inventors Murphy, Andrew J.; Shanker, Gopi Y.; Yancopoulos, George D.

Agent Davies Collison Cave

Pub. Number AU-A-2003301960

PCT Number PCT/US2003/0189

PCT Pub. Number WO2004/043563

Priority 60/423,767 05.11.02 US

Filing date 17 June 2003

Wipo publication date 3 June 2004

Event Publications

1 July 2004 Complete Application Filed

  Priority application(s): 60/423,767 05.11.02 US

8 July 2004 Application Open to Public Inspection

  Published as AU-A-2003301960

15 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003301961-TREATMENT OF OCULAR DISEASE

2003301959-SUBSTITUTED CYCLOALKYL P1' HEPATITIS C VIRUS INHIBITORS